183 related articles for article (PubMed ID: 25394853)
1. Burden of Illness in Hereditary Angioedema: A Conceptual Model.
Bygum A; Aygören-Pürsün E; Beusterien K; Hautamaki E; Sisic Z; Wait S; Boysen HB; Caballero T
Acta Derm Venereol; 2015 Jul; 95(6):706-10. PubMed ID: 25394853
[TBL] [Abstract][Full Text] [Related]
2. The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe.
Caballero T; Aygören-Pürsün E; Bygum A; Beusterien K; Hautamaki E; Sisic Z; Wait S; Boysen HB
Allergy Asthma Proc; 2014; 35(1):47-53. PubMed ID: 24268449
[TBL] [Abstract][Full Text] [Related]
3. The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodology.
Bygum A; Aygören-Pürsün E; Caballero T; Beusterien K; Gholizadeh S; Musingarimi P; Wait S; Boysen H
BMC Dermatol; 2012 Apr; 12():4. PubMed ID: 22536794
[TBL] [Abstract][Full Text] [Related]
4. The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression.
Lumry WR; Castaldo AJ; Vernon MK; Blaustein MB; Wilson DA; Horn PT
Allergy Asthma Proc; 2010; 31(5):407-14. PubMed ID: 20929608
[TBL] [Abstract][Full Text] [Related]
5. Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies.
Bonner N; Abetz-Webb L; Renault L; Caballero T; Longhurst H; Maurer M; Christiansen S; Zuraw B;
Health Qual Life Outcomes; 2015 Jul; 13():92. PubMed ID: 26129930
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe.
Aygören-Pürsün E; Bygum A; Beusterien K; Hautamaki E; Sisic Z; Wait S; Boysen HB; Caballero T
Orphanet J Rare Dis; 2014 Jul; 9():99. PubMed ID: 24996814
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey.
Mendivil J; Murphy R; de la Cruz M; Janssen E; Boysen HB; Jain G; Aygören-Pürsün E; Hirji I; Devercelli G
Orphanet J Rare Dis; 2021 Feb; 16(1):94. PubMed ID: 33602292
[TBL] [Abstract][Full Text] [Related]
8. Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema.
Vanya M; Watt M; Shahraz S; Kosmas CE; Rhoten S; Costa-Cabral S; Mendivil J; Devercelli G; Weller K
J Patient Rep Outcomes; 2023 Apr; 7(1):33. PubMed ID: 37012445
[TBL] [Abstract][Full Text] [Related]
9. The burden of illness in patients with hereditary angioedema.
Banerji A
Ann Allergy Asthma Immunol; 2013 Nov; 111(5):329-36. PubMed ID: 24125136
[TBL] [Abstract][Full Text] [Related]
10. Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden.
Nordenfelt P; Dawson S; Wahlgren CF; Lindfors A; Mallbris L; Björkander J
Allergy Asthma Proc; 2014; 35(2):185-90. PubMed ID: 24411585
[TBL] [Abstract][Full Text] [Related]
11. Estimation of EuroQol 5-Dimensions health status utility values in hereditary angioedema.
Aygören-Pürsün E; Bygum A; Beusterien K; Hautamaki E; Sisic Z; Boysen HB; Caballero T
Patient Prefer Adherence; 2016; 10():1699-707. PubMed ID: 27660419
[TBL] [Abstract][Full Text] [Related]
12. Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project.
Prior N; Remor E; Gómez-Traseira C; López-Serrano C; Cabañas R; Contreras J; Campos Á; Cardona V; Cimbollek S; González-Quevedo T; Guilarte M; de Rojas DH; Marcos C; Rubio M; Tejedor-Alonso MÁ; Caballero T
Health Qual Life Outcomes; 2012 Jul; 10():82. PubMed ID: 22817696
[TBL] [Abstract][Full Text] [Related]
13. Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy.
Anderson J; Levy DS; Lumry W; Koochaki P; Lanar S; Henry Li H
Allergy Asthma Clin Immunol; 2021 Jun; 17(1):60. PubMed ID: 34176500
[TBL] [Abstract][Full Text] [Related]
14. Meeting the challenges and burdens associated with hereditary angioedema.
Toscani M; Riedl M
Manag Care; 2011 Sep; 20(9):44-51. PubMed ID: 21991862
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic Treatment in Hereditary Angioedema Is Associated with Reduced Anxiety in Patients in Leipzig, Germany.
Zarnowski J; Rabe M; Kage P; Simon JC; Treudler R
Int Arch Allergy Immunol; 2021; 182(9):819-826. PubMed ID: 33887730
[TBL] [Abstract][Full Text] [Related]
16. Economic costs associated with acute attacks and long-term management of hereditary angioedema.
Wilson DA; Bork K; Shea EP; Rentz AM; Blaustein MB; Pullman WE
Ann Allergy Asthma Immunol; 2010 Apr; 104(4):314-20. PubMed ID: 20408341
[TBL] [Abstract][Full Text] [Related]
17. Before and after, the impact of available on-demand treatment for HAE.
Christiansen SC; Bygum A; Banerji A; Busse P; Li H; Lumry W; Davis-Lorton M; Bernstein JA; Frank MM; Castaldo A; Long JF; Riedl M; Zuraw BL
Allergy Asthma Proc; 2015; 36(2):145-50. PubMed ID: 25715243
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.
Ohsawa I; Honda D; Nagamachi S; Hisada A; Shimamoto M; Inoshita H; Mano S; Tomino Y
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):492-8. PubMed ID: 25872948
[TBL] [Abstract][Full Text] [Related]
19. Hereditary angioedema in Greece: the first results of the greek hereditary angioedema registry.
Psarros F; Koutsostathis N; Farmaki E; Speletas MG; Germenis AE
Int Arch Allergy Immunol; 2014; 164(4):326-32. PubMed ID: 25277223
[TBL] [Abstract][Full Text] [Related]
20. Hereditary angioedema - consequences of a new treatment paradigm in Denmark.
Bygum A
Acta Derm Venereol; 2014 Jul; 94(4):436-41. PubMed ID: 24202369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
